Andrzej Jakubowiak to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.251
-
Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies. Leuk Lymphoma. 2022 10; 63(10):2413-2421.
Score: 0.200
-
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. Cancer Cell. 2022 11 14; 40(11):1358-1373.e8.
Score: 0.052